Immortalization of human normal and NF1 neurofibroma Schwann cells

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Laboratory Investigation

• Publication date

  2016-09-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/labinvest.2016.88PMID 27617404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas

  2017cited by this paper
• A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor

  2015cited by this paper
• Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.

  2015cited by this paper
• Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma

  2015cited by this paper
• Neurofibromatosis-related tumors: emerging biology and therapies

  2015cited by this paper
• Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis.

  2014cited by this paper
• Somatic neurofibromatosis type 1 (NF1) inactivation events in cutaneous neurofibromas of a single NF1 patient

  2014cited by this paper
• Advances in the treatment of neurofibromatosis-associated tumours

  2013cited by this paper
• Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.

  2013cited by this paper
• Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and genetic pathways driving tumorigenesis

  2013cited by this paper
• Regulation of mTOR Complex 2 Signaling in Neurofibromatosis 2–Deficient Target Cell Types

  2012cited by this paper
• Human Schwann Cells Retain Essential Phenotype Characteristics After Immortalization

  2012cited by this paper
• Alternative splicing of the neurofibromatosis type I pre-mRNA.

  2012cited by this paper
• PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors.

  2012cited by this paper
• Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST

  2012cited by this paper
• Neurofibromatosis type 1-associated tumours: Their somatic mutational spectrum and pathogenesis

  2011cited by this paper
• Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service

  2010cited by this paper
• Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells

  2010cited by this paper
• Lentiviral vector transduction of dendritic cells for novel vaccine strategies.

  2010cited by this paper
• Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings

  2010cited by this paper
• Analysis of NF1 mutation mechanisms

  2009cited by this paper
• Transfection of adult canine Schwann cells and olfactory ensheathing cells at early and late passage with human TERT differentially affects growth factor responsiveness and in vitro growth.

  2009cited by this paper
• Cdk2 and Cdk4 Regulate the Centrosome Cycle and Are Critical Mediators of Centrosome Amplification in p53-Null Cells

  2009cited by this paper
• An orthotopic xenograft model of intraneural NF1 MPNST suggests a potential association between steroid hormones and tumor cell proliferation

  2007cited by this paper
• Plexiform‐like neurofibromas develop in the mouse by intraneural xenograft of an NF1 tumor‐derived Schwann cell line

  2007cited by this paper
• Lentiviral vector-mediated gene transfer in embryonic stem cells.

  2006cited by this paper
• Methylation of the p16INK4a promoter region in telomerase immortalized human keratinocytes co-cultured with feeder cells

  2006cited by this paper
• Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins

  2004cited by this paper
• RT-PCR splicing analysis of the NF1 open reading frame

  2002cited by this paper
• Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells.

  2001cited by this paper
• Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations.

  2000cited by this paper
• Long‐term culture and characterization of human neurofibroma‐derived Schwann cells

  2000cited by this paper
• Human Keratinocytes That Express hTERT and Also Bypass a p16INK4a-Enforced Mechanism That Limits Life Span Become Immortal yet Retain Normal Growth and Differentiation Characteristics

  2000cited by this paper
• Culture of cytogenetically abnormal Schwann cells from benign and malignant NF1 tumors

  2000cited by this paper
• Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group

  2000cited by this paper
• Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects

  2000cited by this paper
• Loss of NF1 allele in schwann cells but not in fibroblasts derived from an NF1‐associated neurofibroma

  1999cited by this paper
• Replicative senescence in human uroepithelial cells.

  1999cited by this paper
• Human Endothelial Cell Life Extension by Telomerase Expression*

  1999cited by this paper
• Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation

  1998cited by this paper
• A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

  1998cited by this paper
• Extension of life-span by introduction of telomerase into normal human cells.

  1998cited by this paper
• Cell aging in vivo and in vitro.

  1997cited by this paper
• NF1 mutation analysis using a combined heteroduplex/SSCP approach

  1997cited by this paper
• The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

  1997cited by this paper
• Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells.

  1996cited by this paper
• HUMAN PAPILLOMAVIRUS TYPE 16 E7 ALLEVIATES A PROLIFERATION BLOCK IN EARLY PASSAGE HUMAN MAMMARY EPITHELIAL CELLS

  1996cited by this paper
• Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues.

  1995cited by this paper
• Efficient nuclear localization and immortalizing ability, two functions dependent on the adenovirus type 5 (Ad5) E1A second exon, are necessary for cotransformation with Ad5 E1B but not with T24ras

  1995cited by this paper
• Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene

  1995cited by this paper
• Expression of two types of neurofibromatosis type 1 gene transcripts in gastric cancers and comparison of GAP activities.

  1992cited by this paper
• Epstein‐Barr Viral Latency and Cell Immortalization as Targets for Antisense Oligomers a

  1992cited by this paper
• Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells.

  1991cited by this paper
• HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.

  1989cited by this paper

• Variation in guide RNA library representation results in gene effect score bias in genome-wide CRISPR screens.

  2026cites this paper
• Proof-of-principle of NF1 gene therapy in plexiform neurofibroma xenograft mouse models.

  2026cites this paper
• IFN signaling is associated with radiotherapy response in malignant peripheral nerve sheath tumors.

  2026cites this paper
• Ataluren‐Induced Functional Restoration of Neurofibromin in Fibroblasts From Neurofibromatosis Type 1 Patients With Nonsense Mutations

  2025cites this paper
• BET proteins mediate survival mechanisms in human schwannoma model cells challenged with trametinib but not brigatinib

  2025cites this paper
• Schwann cells drive tumor progression through neuro-tumor crosstalk.

  2025cites this paper
• Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors

  2025cites this paper
• Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors

  2025cites this paper
• Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors

  2025cites this paper
• The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas

  2025cites this paper
• Active Merlin Binds RalB to Regulate Exocytosis

  2025cites this paper
• The RXR Agonist MSU-42011 Reduces Tumor Burden in a Murine Preclinical NF1-Deficient Model

  2025cites this paper
• Establishment and evaluation of an immortalized dzo kidney cell line

  2025cites this paper
• SNX-2112 inhibits the ERBB3high tumor population in Plexiform Neurofibromas

  2025cites this paper
• Silk fibroin-hyaluronic acid nanofibers for peripheral nerve regeneration

  2025cites this paper
• Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas

  2025cites this paper
• DLK1 distinguishes subsets of NF1-associated malignant peripheral nerve sheath tumors with divergent molecular signatures.

  2025cites this paper
• Schwann Cells Deficient in Neurofibromin Lack Sensitivity to Their Biomechanical Microenvironment

  2025cites this paper
• Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism

  2025influential citation
• Establishment of a human ovarian endometrioid carcinoma cell line by constitutive expression of cyclin-dependent kinase 4, cyclin D1 and telomerase reverse transcriptase

  2025cites this paper
• Unraveling the Peripheral Nervous System's Role in Tumor: A Double-edged Sword.

  2025cites this paper
• High-content microscopy and machine learning characterize a cell morphology signature of NF1 genotype in Schwann cells

  2025cites this paper
• Neurofibromatosis Type 1 and the Search for Effective Tumor Therapies Using High-Throughput Drug Screening

  2025influential citation
• Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Plexiform Neurofibroma Cells at Doses That Do Not Affect Patient-Matched Schwann Cells

  2024influential citation
• Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors

  2024cites this paper
• Typical NF2 and LTZR1 mutations are retained in an immortalized human schwann cell model of schwannomatosis

  2024cites this paper
• Cold Atmospheric Plasma Induces Growth Arrest and Apoptosis in Neurofibromatosis Type 1-Associated Peripheral Nerve Sheath Tumor Cells

  2024cites this paper
• Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors

  2024cites this paper
• Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers

  2024cites this paper
• Do metabolic deficits contribute to sleep disruption in monogenic intellectual disability syndromes?

  2024cites this paper
• Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss

  2024cites this paper
• snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response

  2024cites this paper
• G6PD and ACSL3 are synthetic lethal partners of NF2 in Schwann cells

  2024cites this paper
• A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening

  2024cites this paper
• Tumors of the nervous system and hearing loss: Beyond vestibular schwannomas.

  2024cites this paper
• Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance

  2024cites this paper
• Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.

  2023cites this paper
• Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization

  2023cites this paper
• Schwann cells modulate nociception in neurofibromatosis 1

  2023cites this paper
• Modeling human cancer predisposition syndromes using CRISPR/Cas9 in human cell line models

  2023cites this paper
• Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities

  2023cites this paper
• A Call for Discovery and Therapeutic Development for Cutaneous Neurofibromas.

  2023cites this paper
• Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1

  2023cites this paper
• Combined CDK4/6 and ERK1/2 inhibition enhances anti-tumor activity in NF1-associated plexiform neurofibroma.

  2023cites this paper
• Single-cell sequencing analysis reveals development and differentiation trajectory of Schwann cells manipulated by M. leprae

  2023cites this paper
• Econazole selectively induces cell death in NF1-homozygous mutant tumor cells

  2023cites this paper
• Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency

  2023cites this paper
• Spatial gene expression profiling unveils immuno-oncogenic programs of NF1-associated peripheral nerve sheath tumor progression.

  2023cites this paper
• Human Cytomegalovirus Utilizes Multiple Viral Proteins to Regulate the Basement Membrane Protein Nidogen 1

  2022cites this paper
• Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2

  2022cites this paper
• Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas

  2022cites this paper
• Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2

  2022cites this paper
• Malignant Peripheral Nerve Sheath Tumor: Models, Biology, and Translation

  2022cites this paper
• Targeted exon skipping of NF1 exon 17 as a therapeutic for neurofibromatosis type I

  2022cites this paper
• Modeling iPSC-derived human neurofibroma-like tumors in mice uncovers the heterogeneity of Schwann cells within plexiform neurofibromas.

  2022cites this paper
• A rapid platform for 3D patient-derived cutaneous neurofibroma organoid establishment and screening

  2022cites this paper
• Transcriptional regulation of miR-30a by YAP impacts PTPN13 and KLF9 levels and Schwann cell proliferation

  2021cites this paper
• WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth

  2021cites this paper
• Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3

  2021cites this paper
• Neurofibromin Deficiency and Extracellular Matrix Cooperate to Increase Transforming Potential through FAK-Dependent Signaling

  2021cites this paper
• Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours

  2021cites this paper
• Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor Development

  2021cites this paper
• Selection of internal references for RT-qPCR assays in Neurofibromatosis type 1 (NF1) related Schwann cell lines

  2021cites this paper
• Inhibition of autophagy as a novel therapy for the treatment of neurofibromatosis type 1 tumors

  2021influential citation
• Synthetic lethal screening identifies existing drugs with selective viability effects on Neurofibromatosis type-1 model systems

  2021cites this paper
• Merlin tumor suppressor function is regulated by PIP2-mediated dimerization

  2021cites this paper
• Survival and NF1 Analysis in a Cohort of Orthopedics Patients with Malignant Peripheral Nerve Sheath Tumors

  2021cites this paper
• Purinergic receptor P2RY14 cAMP signaling regulates EGFR-driven Schwann cell precursor self-renewal and nerve tumor initiation in neurofibromatosis

  2021cites this paper
• Schwann cell‐derived exosomes: Janus‐faced mediators of regeneration and disease

  2021cites this paper
• Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1

  2020cites this paper
• New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

  2020cites this paper
• Genomics of Peripheral Nerve Sheath Tumors Associated with Neurofibromatosis Type 1

  2020cites this paper
• Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells.

  2020cites this paper
• Selection of internal references for transcriptomics and RT-qPCR assays in Neurofibromatosis type 1 (NF1) related Schwann cell lines

  2020cites this paper
• Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma

  2020cites this paper
• Stabilization of β-catenin promotes melanocyte specification at the expense of the Schwann cell lineage

  2020cites this paper
• Multidisciplinary Approach to Neurofibromatosis Type 1

  2020influential citation
• Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 17

  2020cites this paper
• YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators

  2020cites this paper
• Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK

  2019cites this paper
• Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas

  2019cites this paper
• Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling

  2019cites this paper
• The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor

  2019cites this paper
• Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside

  2019cites this paper
• EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer

  2019cites this paper
• Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells

  2018cites this paper
• Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1

  2018cites this paper
• Human stem cell modeling in neurofibromatosis type 1 (NF1).

  2018cites this paper
• Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors

  2018cites this paper
• AWARD NUMBER: W81XWH-17-1-0152 TITLE: Identification of Novel Signaling Pathways in NF2 PRINCIPAL INVESTIGATOR: Robert Hennigan CONTRACTING ORGANIZATION: Cincinnati Childrens Hospital

  2018cites this paper
• Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening

  2018influential citation
• Regulation of localization and function of the transcriptional co-activator YAP by angiomotin

  2017cites this paper
• Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.

  2017cites this paper